The Pharmaceutical Benefits Advisory Committee recommended changes to the Pharmaceutical Benefits Scheme (PBS) eligibility criteria of oral treatments for COVID-19. Read more
Health authorities around the world are spending billions on tackling Long COVID, with innovative research projects for new treatments and comprehensive patient support. In Australia, things are a little different. The ABC's Sophie Scott and Stephanie Dalzell recently spoke with Emerge Australia's CEO, Anne Wilson, as part of their story on the Federal Governments underfunding of Long COVID in Australia. Read more
Anne Wilson, Emerge Australia's CEO, has expressed disappointment as the budget provided no funding for sufferers of Long COVID or other post-viral conditions. Read more
Emerge Australia, the national patient organisation providing services and evidence-based education about myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) today issued an alert on a potential major hit to the Federal Budget and health services facing both major parties. Read more
Media Release 12 October 2022 - Members of Parliament across Australia are set to come face to face with the harsh reality of the impact and destruction of the lives of tens of thousands of Australians facing the daily battle of Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), for which there is no known cure. Read more
Emerge Australia presented the keynote address on Sunday 23 July, at the second GPCE conference for 2022 in Perth. Just as at Sydney’s conference, Emerge Australia’s Medical Director Dr Richard Schloeffel, OAM, presented about diagnosis, management and treatment options for Long COVID and ME/CFS. Read more
One of our volunteers, Jenny, Dr Richard Schloeffel and CEO Anne Wilson were recently interviewed for the RMIT City Journal by Rebecca Kazmierczak. Read more
Our International Roundup provides a brief snapshot of some of the ME/CFS research funding, clinical care and advocacy actions around the world in the last few months. Read more
One cold evening in late July, Emerge Australia’s Nurse Educator, Kate Herbert, presented to the Australian Physiotherapy Association pain special interest group about ME/CFS. With over 100 participants, including attendees also from other special interest groups, this was the most well attended presentation Kate has delivered to date. Read more
Current medical predictions suggesting up to 325,000 people may be affected by Long COVID, in addition to the 250,000 living with ME/CFS, will be the foundation of a major post viral attack on the Australian community in coming years threatening national and state budgets. Read more